• Chair of the Board of Novo. Nordisk Foundation.
• Vice Chair of the Board of Ferring Pharmaceuticals.
• Member of the Board of Jungbunzlauer Suisse AG.
• Adjunct professor at the University of Copenhagen’s School of Life Sciences.
• Adjunct professor at Center for Corporate Governance at Copenhagen Business School

• Chair of Novo Holdings A/S, 2018-2025.
• President and CEO of Novo Nordisk A/S, 2000-2016.
• Member of the corporate management team in Novozymes A/S, 1994-2000.

• Considered not independent under the Danish Corporate Governance Recommendations.
• Chair of the Board of Directors since November 2025.
• Chair of the Chair Committee since November 2025.
• Chair of the People & Governance Committee since November 2025.

• Global corporate leadership.
• Healthcare & pharma industry.
• Business development, M&A and external innovation sourcing.
• Medicine & science.
• Human capital. management
• Environmental, social & governance (ESG)

• 1981: MSc in Forestry from the Copenhagen Royal Veterinary and Agricultural University, Denmark.
• 1983: BSc in International Economics from Copenhagen Business School.

Danish. Born in 1954. Male.